Obesity as a susceptibility factor to indoor particulate matter health effects in COPD

Meredith McCormack, Andrew J. Belli, Deepak A. Kaji, Elizabeth C. Matsui, Emily Brigham, Roger Peng, Cortlandt Sellers, D'Ann L. Williams, Gregory B Diette, Patrick N Breysse, Nadia Hansel

Research output: Contribution to journalArticle

Abstract

Our goal was to investigate whether obesity increases susceptibility to the adverse effects of indoor particulate matter on respiratory morbidity among individuals with chronic obstructive pulmonary disease (COPD). Participants with COPD were studied at baseline, 3 and 6 months. Obesity was defined as a body mass index ?30 kg·m-2. At each time point, indoor air was sampled for 5-7 days and particulate matter (PM) with an aerodynamic size ?2.5 μm (PM2.5) and 2.5-10 μm (PM2.5-10) was measured. Respiratory symptoms, health status, rescue medication use, exacerbations, blood biomarkers and exhaled nitric oxide were assessed simultaneously. Of the 84 participants enrolled, 56% were obese and all were former smokers with moderate-to-severe COPD. Obese participants tended to have less severe disease as assessed by Global Initiative for Chronic Obstructive Pulmonary Disease stage and fewer pack-years of smoking. There was evidence that obesity modified the effects of indoor PM on COPD respiratory outcomes. Increases in PM2.5 and PM2.5-10 were associated with greater increases in nocturnal symptoms, dyspnoea and rescue medication use among obese versus non-obese participants. The impact of indoor PM on exacerbations, respiratory status and wheeze also tended to be greater among obese versus non-obese participants, as were differences in airway and systemic inflammatory responses to indoor PM. We found evidence that obesity was associated with exaggerated responses to indoor fine and coarse PM exposure among individuals with COPD.

Original languageEnglish (US)
Pages (from-to)1248-1257
Number of pages10
JournalEuropean Respiratory Journal
Volume45
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Particulate Matter
Chronic Obstructive Pulmonary Disease
Obesity
Health
Dyspnea
Health Status
Nitric Oxide
Body Mass Index
Biomarkers
Smoking
Air
Morbidity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Obesity as a susceptibility factor to indoor particulate matter health effects in COPD. / McCormack, Meredith; Belli, Andrew J.; Kaji, Deepak A.; Matsui, Elizabeth C.; Brigham, Emily; Peng, Roger; Sellers, Cortlandt; Williams, D'Ann L.; Diette, Gregory B; Breysse, Patrick N; Hansel, Nadia.

In: European Respiratory Journal, Vol. 45, No. 5, 01.05.2015, p. 1248-1257.

Research output: Contribution to journalArticle

McCormack, Meredith ; Belli, Andrew J. ; Kaji, Deepak A. ; Matsui, Elizabeth C. ; Brigham, Emily ; Peng, Roger ; Sellers, Cortlandt ; Williams, D'Ann L. ; Diette, Gregory B ; Breysse, Patrick N ; Hansel, Nadia. / Obesity as a susceptibility factor to indoor particulate matter health effects in COPD. In: European Respiratory Journal. 2015 ; Vol. 45, No. 5. pp. 1248-1257.
@article{ea4514168a08474dbb2fedc8d01068ca,
title = "Obesity as a susceptibility factor to indoor particulate matter health effects in COPD",
abstract = "Our goal was to investigate whether obesity increases susceptibility to the adverse effects of indoor particulate matter on respiratory morbidity among individuals with chronic obstructive pulmonary disease (COPD). Participants with COPD were studied at baseline, 3 and 6 months. Obesity was defined as a body mass index ?30 kg·m-2. At each time point, indoor air was sampled for 5-7 days and particulate matter (PM) with an aerodynamic size ?2.5 μm (PM2.5) and 2.5-10 μm (PM2.5-10) was measured. Respiratory symptoms, health status, rescue medication use, exacerbations, blood biomarkers and exhaled nitric oxide were assessed simultaneously. Of the 84 participants enrolled, 56{\%} were obese and all were former smokers with moderate-to-severe COPD. Obese participants tended to have less severe disease as assessed by Global Initiative for Chronic Obstructive Pulmonary Disease stage and fewer pack-years of smoking. There was evidence that obesity modified the effects of indoor PM on COPD respiratory outcomes. Increases in PM2.5 and PM2.5-10 were associated with greater increases in nocturnal symptoms, dyspnoea and rescue medication use among obese versus non-obese participants. The impact of indoor PM on exacerbations, respiratory status and wheeze also tended to be greater among obese versus non-obese participants, as were differences in airway and systemic inflammatory responses to indoor PM. We found evidence that obesity was associated with exaggerated responses to indoor fine and coarse PM exposure among individuals with COPD.",
author = "Meredith McCormack and Belli, {Andrew J.} and Kaji, {Deepak A.} and Matsui, {Elizabeth C.} and Emily Brigham and Roger Peng and Cortlandt Sellers and Williams, {D'Ann L.} and Diette, {Gregory B} and Breysse, {Patrick N} and Nadia Hansel",
year = "2015",
month = "5",
day = "1",
doi = "10.1183/09031936.00081414",
language = "English (US)",
volume = "45",
pages = "1248--1257",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "5",

}

TY - JOUR

T1 - Obesity as a susceptibility factor to indoor particulate matter health effects in COPD

AU - McCormack, Meredith

AU - Belli, Andrew J.

AU - Kaji, Deepak A.

AU - Matsui, Elizabeth C.

AU - Brigham, Emily

AU - Peng, Roger

AU - Sellers, Cortlandt

AU - Williams, D'Ann L.

AU - Diette, Gregory B

AU - Breysse, Patrick N

AU - Hansel, Nadia

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Our goal was to investigate whether obesity increases susceptibility to the adverse effects of indoor particulate matter on respiratory morbidity among individuals with chronic obstructive pulmonary disease (COPD). Participants with COPD were studied at baseline, 3 and 6 months. Obesity was defined as a body mass index ?30 kg·m-2. At each time point, indoor air was sampled for 5-7 days and particulate matter (PM) with an aerodynamic size ?2.5 μm (PM2.5) and 2.5-10 μm (PM2.5-10) was measured. Respiratory symptoms, health status, rescue medication use, exacerbations, blood biomarkers and exhaled nitric oxide were assessed simultaneously. Of the 84 participants enrolled, 56% were obese and all were former smokers with moderate-to-severe COPD. Obese participants tended to have less severe disease as assessed by Global Initiative for Chronic Obstructive Pulmonary Disease stage and fewer pack-years of smoking. There was evidence that obesity modified the effects of indoor PM on COPD respiratory outcomes. Increases in PM2.5 and PM2.5-10 were associated with greater increases in nocturnal symptoms, dyspnoea and rescue medication use among obese versus non-obese participants. The impact of indoor PM on exacerbations, respiratory status and wheeze also tended to be greater among obese versus non-obese participants, as were differences in airway and systemic inflammatory responses to indoor PM. We found evidence that obesity was associated with exaggerated responses to indoor fine and coarse PM exposure among individuals with COPD.

AB - Our goal was to investigate whether obesity increases susceptibility to the adverse effects of indoor particulate matter on respiratory morbidity among individuals with chronic obstructive pulmonary disease (COPD). Participants with COPD were studied at baseline, 3 and 6 months. Obesity was defined as a body mass index ?30 kg·m-2. At each time point, indoor air was sampled for 5-7 days and particulate matter (PM) with an aerodynamic size ?2.5 μm (PM2.5) and 2.5-10 μm (PM2.5-10) was measured. Respiratory symptoms, health status, rescue medication use, exacerbations, blood biomarkers and exhaled nitric oxide were assessed simultaneously. Of the 84 participants enrolled, 56% were obese and all were former smokers with moderate-to-severe COPD. Obese participants tended to have less severe disease as assessed by Global Initiative for Chronic Obstructive Pulmonary Disease stage and fewer pack-years of smoking. There was evidence that obesity modified the effects of indoor PM on COPD respiratory outcomes. Increases in PM2.5 and PM2.5-10 were associated with greater increases in nocturnal symptoms, dyspnoea and rescue medication use among obese versus non-obese participants. The impact of indoor PM on exacerbations, respiratory status and wheeze also tended to be greater among obese versus non-obese participants, as were differences in airway and systemic inflammatory responses to indoor PM. We found evidence that obesity was associated with exaggerated responses to indoor fine and coarse PM exposure among individuals with COPD.

UR - http://www.scopus.com/inward/record.url?scp=84928983962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928983962&partnerID=8YFLogxK

U2 - 10.1183/09031936.00081414

DO - 10.1183/09031936.00081414

M3 - Article

C2 - 25573407

AN - SCOPUS:84928983962

VL - 45

SP - 1248

EP - 1257

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 5

ER -